Cargando…

Recent advances in research on multistage tumorigenesis

Tumour development is a multi-step process during which genetic and epigenetic events determine the transition from a normal to a malignant cellular state. In the past decade, extensive effort has been made not only to define the molecular mechanisms underlying progression to malignancy but also to...

Descripción completa

Detalles Bibliográficos
Autores principales: Compagni, A, Christofori, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374546/
https://www.ncbi.nlm.nih.gov/pubmed/10883659
http://dx.doi.org/10.1054/bjoc.2000.1309
_version_ 1782154479264595968
author Compagni, A
Christofori, G
author_facet Compagni, A
Christofori, G
author_sort Compagni, A
collection PubMed
description Tumour development is a multi-step process during which genetic and epigenetic events determine the transition from a normal to a malignant cellular state. In the past decade, extensive effort has been made not only to define the molecular mechanisms underlying progression to malignancy but also to predict the development of the disease and to identify possible molecular targets for therapy. Common to most tumours, several regulatory circuits are altered during multistage tumour progression, most importantly, the control of proliferation, the balance between cell survival and programmed cell death (apoptosis), the communication with neighbouring cells and the extracellular matrix, the induction of tumour neovascularization (angiogenesis) and, finally, tumour cell migration, invasion and metastatic dissemination. De-regulation of each of these processes represents a rate-limiting step for tumour development and, hence, has to be achieved by tumour cells in a highly selective manner during tumour progression. In this review we summarize recent advances in cancer research that have provided new insights in the molecular mechanisms underlying the transition between one tumour stage and the next and into their concerted action during tumour progression. Cultured human tumour cell lines as well as transgenic and knock-out mouse models of tumorigenesis have been instrumental in these experimental approaches. © 2000 Cancer Research Campaign
format Text
id pubmed-2374546
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23745462009-09-10 Recent advances in research on multistage tumorigenesis Compagni, A Christofori, G Br J Cancer Millennium Mini-Review Tumour development is a multi-step process during which genetic and epigenetic events determine the transition from a normal to a malignant cellular state. In the past decade, extensive effort has been made not only to define the molecular mechanisms underlying progression to malignancy but also to predict the development of the disease and to identify possible molecular targets for therapy. Common to most tumours, several regulatory circuits are altered during multistage tumour progression, most importantly, the control of proliferation, the balance between cell survival and programmed cell death (apoptosis), the communication with neighbouring cells and the extracellular matrix, the induction of tumour neovascularization (angiogenesis) and, finally, tumour cell migration, invasion and metastatic dissemination. De-regulation of each of these processes represents a rate-limiting step for tumour development and, hence, has to be achieved by tumour cells in a highly selective manner during tumour progression. In this review we summarize recent advances in cancer research that have provided new insights in the molecular mechanisms underlying the transition between one tumour stage and the next and into their concerted action during tumour progression. Cultured human tumour cell lines as well as transgenic and knock-out mouse models of tumorigenesis have been instrumental in these experimental approaches. © 2000 Cancer Research Campaign Nature Publishing Group 2000-07 2000-06-02 /pmc/articles/PMC2374546/ /pubmed/10883659 http://dx.doi.org/10.1054/bjoc.2000.1309 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Millennium Mini-Review
Compagni, A
Christofori, G
Recent advances in research on multistage tumorigenesis
title Recent advances in research on multistage tumorigenesis
title_full Recent advances in research on multistage tumorigenesis
title_fullStr Recent advances in research on multistage tumorigenesis
title_full_unstemmed Recent advances in research on multistage tumorigenesis
title_short Recent advances in research on multistage tumorigenesis
title_sort recent advances in research on multistage tumorigenesis
topic Millennium Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374546/
https://www.ncbi.nlm.nih.gov/pubmed/10883659
http://dx.doi.org/10.1054/bjoc.2000.1309
work_keys_str_mv AT compagnia recentadvancesinresearchonmultistagetumorigenesis
AT christoforig recentadvancesinresearchonmultistagetumorigenesis